Recent News

Envoy Medical Reports Full Year 2025 Financial Results

Mar 23, 2026 8:12:17 AM

Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to ...

Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant

Mar 11, 2026 8:35:46 AM

First Cochlear Implant Company to Announce Completed Enrollment of a U.S. Pivotal Clinical Trial for...

Envoy Medical Regains Compliance with Nasdaq Listing Requirement

Feb 24, 2026 9:28:01 AM

White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical® Inc. (NASDAQ: COCH...

Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space

Feb 23, 2026 8:47:02 AM

White Bear Lake, Minnesota--(Newsfile Corp. - February 23, 2026) - Envoy Medical® Inc. (NASDAQ: COCH...

Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial

Feb 19, 2026 8:39:40 AM

Financing was led by new investor and top-tier healthcare fund Nantahala Capital and longtime Envoy ...

Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

Feb 17, 2026 9:04:33 AM

45 of 56 Patients Implanted; Enrollment Completion Anticipated by End of March

Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering

Feb 11, 2026 8:40:36 AM

$30.0 million upfront with up to an additional $48.0 million of potential aggregate gross proceeds u...

Press release design titled "Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim® Cochlear Implant"

Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim® Cochlear Implant

Dec 18, 2025 9:18:44 AM

Enrollment momentum accelerates as Company advances toward full enrollment

Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio

Dec 16, 2025 8:56:50 AM

Patent strengthens Company's global intellectual property portfolio and reinforces the Company's com...

Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim® Cochlear Implant

Dec 10, 2025 8:22:24 AM

Momentum continues to build for Company as series of clinical milestones are met, design choices cem...

*The materials and resources presented are intended to be an educational resource for general purposes only. They are not intended to constitute medical or business advice or in any way replace the independent medical judgment of a trained and licensed physician. Each person’s situation is unique and risks, outcomes, experience and results may vary. CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by federal (or United States) law to investigational use.

**See Important Information here.

News Room